John Michael Kelley, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placebo Effect | 21 | 2021 | 518 | 3.260 |
Why?
|
| Irritable Bowel Syndrome | 16 | 2022 | 453 | 2.200 |
Why?
|
| Placebos | 10 | 2022 | 1666 | 0.830 |
Why?
|
| Antiparkinson Agents | 2 | 2015 | 184 | 0.700 |
Why?
|
| Physician-Patient Relations | 10 | 2018 | 3253 | 0.610 |
Why?
|
| Classification | 1 | 2018 | 128 | 0.600 |
Why?
|
| Acupuncture Therapy | 9 | 2023 | 486 | 0.560 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 493 | 0.450 |
Why?
|
| Empathy | 5 | 2023 | 474 | 0.430 |
Why?
|
| Marriage | 1 | 2013 | 349 | 0.370 |
Why?
|
| Consensus | 3 | 2021 | 3134 | 0.350 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2017 | 10218 | 0.330 |
Why?
|
| Ceremonial Behavior | 1 | 2008 | 17 | 0.320 |
Why?
|
| Plant Oils | 2 | 2021 | 198 | 0.310 |
Why?
|
| Research Subjects | 1 | 2010 | 249 | 0.300 |
Why?
|
| Interpersonal Relations | 2 | 2013 | 1437 | 0.300 |
Why?
|
| Burning Mouth Syndrome | 2 | 2017 | 25 | 0.290 |
Why?
|
| Parkinson Disease | 2 | 2015 | 2867 | 0.280 |
Why?
|
| Clonazepam | 2 | 2017 | 135 | 0.280 |
Why?
|
| Treatment Outcome | 19 | 2023 | 64681 | 0.280 |
Why?
|
| Sensory Thresholds | 1 | 2008 | 377 | 0.270 |
Why?
|
| Touch | 1 | 2008 | 310 | 0.260 |
Why?
|
| Tai Ji | 1 | 2008 | 291 | 0.240 |
Why?
|
| Complementary Therapies | 1 | 2008 | 487 | 0.230 |
Why?
|
| Nonverbal Communication | 2 | 2022 | 62 | 0.230 |
Why?
|
| Double-Blind Method | 7 | 2022 | 12341 | 0.210 |
Why?
|
| Self Care | 1 | 2008 | 795 | 0.210 |
Why?
|
| Dyspepsia | 1 | 2023 | 116 | 0.210 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2014 | 251 | 0.190 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2022 | 431 | 0.170 |
Why?
|
| Patient Satisfaction | 5 | 2011 | 3453 | 0.170 |
Why?
|
| Neuronal Plasticity | 1 | 2008 | 1432 | 0.170 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 509 | 0.160 |
Why?
|
| Learning | 1 | 2008 | 1737 | 0.160 |
Why?
|
| Motivation | 1 | 2008 | 2002 | 0.160 |
Why?
|
| Catastrophization | 1 | 2022 | 349 | 0.150 |
Why?
|
| Skin | 2 | 2009 | 4473 | 0.150 |
Why?
|
| Leukopoiesis | 1 | 2018 | 54 | 0.150 |
Why?
|
| Fish Proteins | 1 | 2018 | 47 | 0.150 |
Why?
|
| Attention | 1 | 2008 | 2394 | 0.150 |
Why?
|
| Research Design | 4 | 2022 | 6180 | 0.140 |
Why?
|
| Adult | 27 | 2022 | 221119 | 0.140 |
Why?
|
| Pain Measurement | 4 | 2022 | 3549 | 0.130 |
Why?
|
| Paresthesia | 1 | 2017 | 161 | 0.130 |
Why?
|
| Chemokine CXCL12 | 1 | 2018 | 454 | 0.130 |
Why?
|
| Humans | 53 | 2023 | 761208 | 0.130 |
Why?
|
| Phototherapy | 2 | 2009 | 368 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2022 | 1067 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2010 | 3434 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2012 | 4767 | 0.120 |
Why?
|
| Endpoint Determination | 2 | 2014 | 590 | 0.120 |
Why?
|
| Personality | 2 | 2014 | 553 | 0.110 |
Why?
|
| Anticipation, Psychological | 1 | 2014 | 84 | 0.110 |
Why?
|
| Female | 32 | 2022 | 392544 | 0.110 |
Why?
|
| Receptors, CXCR4 | 1 | 2018 | 727 | 0.110 |
Why?
|
| Sex Characteristics | 2 | 2014 | 2640 | 0.110 |
Why?
|
| Courtship | 1 | 2013 | 34 | 0.110 |
Why?
|
| Male | 31 | 2022 | 360693 | 0.100 |
Why?
|
| Watchful Waiting | 1 | 2017 | 489 | 0.100 |
Why?
|
| Pain Perception | 1 | 2014 | 196 | 0.100 |
Why?
|
| Psychological Theory | 1 | 2013 | 176 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 2691 | 0.100 |
Why?
|
| Therapeutic Touch | 1 | 2011 | 9 | 0.090 |
Why?
|
| Drug Labeling | 1 | 2014 | 248 | 0.090 |
Why?
|
| Physical Stimulation | 2 | 2014 | 517 | 0.090 |
Why?
|
| Anxiety | 3 | 2022 | 4569 | 0.090 |
Why?
|
| Albuterol | 1 | 2011 | 211 | 0.090 |
Why?
|
| Mentha piperita | 2 | 2021 | 17 | 0.090 |
Why?
|
| Analgesia | 1 | 2014 | 461 | 0.090 |
Why?
|
| Leukocytes | 1 | 2018 | 2025 | 0.090 |
Why?
|
| Physicians | 2 | 2023 | 4584 | 0.080 |
Why?
|
| Osteoprotegerin | 1 | 2009 | 177 | 0.080 |
Why?
|
| Middle Aged | 19 | 2022 | 220853 | 0.080 |
Why?
|
| Lasers, Semiconductor | 1 | 2009 | 41 | 0.080 |
Why?
|
| Flowers | 1 | 2008 | 31 | 0.080 |
Why?
|
| Psychoanalytic Therapy | 1 | 2010 | 228 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2022 | 8642 | 0.080 |
Why?
|
| Facial Dermatoses | 1 | 2009 | 86 | 0.080 |
Why?
|
| Pediatrics | 1 | 2023 | 3590 | 0.070 |
Why?
|
| Sexual Partners | 1 | 2013 | 800 | 0.070 |
Why?
|
| Bronchodilator Agents | 1 | 2011 | 512 | 0.070 |
Why?
|
| Waiting Lists | 2 | 2009 | 766 | 0.070 |
Why?
|
| Neurosciences | 1 | 2012 | 369 | 0.070 |
Why?
|
| Skin Aging | 1 | 2009 | 140 | 0.070 |
Why?
|
| Afferent Pathways | 1 | 2008 | 298 | 0.070 |
Why?
|
| Brain | 3 | 2023 | 27092 | 0.070 |
Why?
|
| Cosmetic Techniques | 1 | 2009 | 147 | 0.070 |
Why?
|
| Orientation | 1 | 2008 | 320 | 0.070 |
Why?
|
| Discrimination Learning | 1 | 2008 | 278 | 0.070 |
Why?
|
| Personality Inventory | 1 | 2009 | 1018 | 0.070 |
Why?
|
| Time | 1 | 2008 | 545 | 0.070 |
Why?
|
| Posture | 1 | 2010 | 956 | 0.070 |
Why?
|
| Quality of Life | 5 | 2023 | 13367 | 0.070 |
Why?
|
| Blepharoplasty | 1 | 2006 | 61 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3388 | 0.060 |
Why?
|
| Administration, Topical | 2 | 2017 | 703 | 0.060 |
Why?
|
| Fingers | 1 | 2008 | 506 | 0.060 |
Why?
|
| Blepharoptosis | 1 | 2006 | 144 | 0.060 |
Why?
|
| Space Perception | 1 | 2008 | 465 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2008 | 496 | 0.060 |
Why?
|
| Interviews as Topic | 4 | 2017 | 2697 | 0.060 |
Why?
|
| Somatosensory Cortex | 1 | 2008 | 512 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2009 | 2277 | 0.060 |
Why?
|
| Video Recording | 1 | 2009 | 965 | 0.060 |
Why?
|
| Eyelids | 1 | 2006 | 278 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 6011 | 0.060 |
Why?
|
| Spirituality | 1 | 2008 | 429 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2012 | 6345 | 0.060 |
Why?
|
| Deception | 2 | 2017 | 99 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2022 | 8519 | 0.050 |
Why?
|
| Otolaryngology | 1 | 2011 | 693 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7407 | 0.050 |
Why?
|
| Headache | 2 | 2022 | 1255 | 0.050 |
Why?
|
| Patients | 1 | 2009 | 906 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 821 | 0.050 |
Why?
|
| Pain | 4 | 2022 | 5072 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2014 | 3571 | 0.050 |
Why?
|
| Republic of Korea | 1 | 2023 | 576 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4788 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2012 | 5885 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2014 | 1701 | 0.050 |
Why?
|
| Adolescent | 5 | 2022 | 88298 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2022 | 555 | 0.040 |
Why?
|
| Metronidazole | 1 | 2022 | 232 | 0.040 |
Why?
|
| Arm Injuries | 1 | 2022 | 156 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 312 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2012 | 2374 | 0.040 |
Why?
|
| Social Support | 1 | 2009 | 2175 | 0.040 |
Why?
|
| Child | 3 | 2023 | 80152 | 0.040 |
Why?
|
| Research | 2 | 2021 | 1976 | 0.040 |
Why?
|
| Facial Expression | 1 | 2022 | 507 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2010 | 10088 | 0.040 |
Why?
|
| Mouthwashes | 1 | 2017 | 57 | 0.040 |
Why?
|
| Benzylamines | 1 | 2018 | 247 | 0.030 |
Why?
|
| Personality Disorders | 1 | 2001 | 719 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 245 | 0.030 |
Why?
|
| Solutions | 1 | 2017 | 410 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18384 | 0.030 |
Why?
|
| Aged | 7 | 2017 | 169288 | 0.030 |
Why?
|
| Palliative Care | 1 | 2010 | 3599 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 7046 | 0.030 |
Why?
|
| Feces | 1 | 2022 | 1490 | 0.030 |
Why?
|
| Wound Healing | 1 | 2006 | 2800 | 0.030 |
Why?
|
| Asthma | 2 | 2011 | 6230 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2009 | 1577 | 0.030 |
Why?
|
| Time Factors | 3 | 2017 | 39957 | 0.030 |
Why?
|
| Fatigue | 1 | 2022 | 1550 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 2421 | 0.030 |
Why?
|
| Functional Laterality | 2 | 2014 | 2257 | 0.030 |
Why?
|
| Tryptamines | 1 | 2014 | 93 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15920 | 0.030 |
Why?
|
| Forearm | 1 | 2014 | 427 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 8003 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1436 | 0.020 |
Why?
|
| Bacteria | 1 | 2022 | 2190 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2014 | 603 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 2809 | 0.020 |
Why?
|
| Physician's Role | 1 | 2017 | 920 | 0.020 |
Why?
|
| Young Adult | 5 | 2017 | 59221 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 15841 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2009 | 109 | 0.020 |
Why?
|
| Touch Perception | 1 | 2011 | 106 | 0.020 |
Why?
|
| Psychoanalysis | 1 | 2010 | 89 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2011 | 225 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2023 | 3885 | 0.020 |
Why?
|
| Sensation | 1 | 2011 | 336 | 0.020 |
Why?
|
| Aging | 1 | 2008 | 8702 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 902 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 1737 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2014 | 1434 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2023 | 6635 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 58952 | 0.020 |
Why?
|
| Rejuvenation | 1 | 2009 | 105 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 958 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2023 | 5775 | 0.020 |
Why?
|
| Social Isolation | 1 | 2009 | 365 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 1813 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13385 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 2082 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 36415 | 0.020 |
Why?
|
| United States | 1 | 2013 | 72339 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2854 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 39126 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2010 | 2359 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3418 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26071 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11856 | 0.010 |
Why?
|
| Perception | 1 | 2006 | 1198 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2009 | 1427 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2014 | 6567 | 0.010 |
Why?
|
| Curriculum | 1 | 2012 | 3741 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2001 | 809 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2017 | 80674 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 12985 | 0.010 |
Why?
|
| Patient Selection | 1 | 2009 | 4246 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23416 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2009 | 54435 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29687 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 20119 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 168079 | 0.000 |
Why?
|